Literature DB >> 7066172

Plasma theophylline concentrations in patients with chronic obstructive airways disease after administration of a new sustained release theophylline formulation.

D R Taylor, C D Kinney, D G McDevitt.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7066172      PMCID: PMC1402057          DOI: 10.1111/j.1365-2125.1982.tb01423.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  6 in total

1.  Dosage of theophylline in bronchial asthma.

Authors:  K M Piafsky; R I Ogilvie
Journal:  N Engl J Med       Date:  1975-06-05       Impact factor: 91.245

2.  Measurement of theophylline in plasma by high performance liquid chromatography.

Authors:  J G Kelly; W J Leahey
Journal:  Br J Clin Pharmacol       Date:  1976-10       Impact factor: 4.335

Review 3.  Clinical pharmacokinetics of theophylline.

Authors:  R I Ogilvie
Journal:  Clin Pharmacokinet       Date:  1978 Jul-Aug       Impact factor: 6.447

4.  Rational intravenous doses of theophylline.

Authors:  P A Mitenko; R I Ogilvie
Journal:  N Engl J Med       Date:  1973-09-20       Impact factor: 91.245

5.  Pharmacokinetics of theophylline. Application to adjustment of the clinical dose of aminophylline.

Authors:  J W Jenne; M S Wyze; F S Rood; F M MacDonald
Journal:  Clin Pharmacol Ther       Date:  1972 May-Jun       Impact factor: 6.875

6.  Plasma theophylline concentrations following the oral administration of microcrystalline theophylline and a new sustained-release theophylline preparation to normal subjects.

Authors:  C J Russell; R K Elwood; C Kinney; D G McDevitt
Journal:  Eur J Clin Pharmacol       Date:  1980-10       Impact factor: 2.953

  6 in total
  2 in total

1.  Is circadian variation in theophylline trough serum concentrations determined by time of dosing?

Authors:  S H Jackson; J K Wiffen; M M Smythe; A Johnston
Journal:  Br J Clin Pharmacol       Date:  1984-06       Impact factor: 4.335

2.  Prediction of optimum oral theophylline dose in patients with obstructive airways disease.

Authors:  D R Taylor; C D Kinney; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1983-06       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.